Epigral Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 5,246.33 million compared to INR 5,621.77 million a year ago. Revenue was INR 5,261.56 million compared to INR 5,667.15 million a year ago.

Net income was INR 772.79 million compared to INR 767.33 million a year ago. Basic earnings per share from continuing operations was INR 18.6 compared to INR 18.47 a year ago. Diluted earnings per share from continuing operations was INR 18.6 compared to INR 18.47 a year ago.